<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04245137</url>
  </required_header>
  <id_info>
    <org_study_id>sEMG-Normal</org_study_id>
    <nct_id>NCT04245137</nct_id>
  </id_info>
  <brief_title>Reference Intervals of the sEMG of the Pelvic Floor in Healthy Female</brief_title>
  <official_title>A Cross-sectional Study of Female Pelvic Floor Surface Electromyography in Chinese Healthy Female</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xi'an Fourth Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maternal and Child Health Hospital of Anhui Province</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ningbo Women and Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gansu Province Maternal and Child Care Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Foshan Maternity and Child Health Care Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a multi-center survey of surface electromyography (sEMG) of pelvic floor
      muscles in healthy female. The aim of the study is to get the reference interval of normal
      pelvic floor sEMG from Chinese women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pelvic floor dysfunction is a group of diseases caused by the damage of pelvic floor
      supporting structure. Pelvic floor muscles play an important role in the maintenance of
      pelvic floor function. Surface electromyography (sEMG) has been widely used to evaluate the
      function of pelvic floor muscles. The sEMG tests, which include pretest and posttest resting
      amplitude (µV), as well as phasic, tonic and endurance contractile amplitude (µV), are
      performed using Vishee neuro-muscle stimulator (MyoTrac Infiniti, model SA9800, Thought
      Technology Ltd., Montreal, Canada), following the Glazer protocols. A pear-shaped vaginal
      probe (serial number DYS180610, type VET-A, produced by Nanjing Vishee Medical Technology,
      Ltd.) is placed into the vagina when sEMG tests are performed. This is a cross-sectional
      survey. The reference intervals of pelvic floor sEMG in healthy female are evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>resting amplitude (µV) pre baseline</measure>
    <time_frame>1 day</time_frame>
    <description>pretest one minute rest</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>coefficients of variability pre baseline</measure>
    <time_frame>1 day</time_frame>
    <description>standard deviation divided by amplitudes at pretest resting period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maximum rapid contraction amplitude (µV)</measure>
    <time_frame>1 day</time_frame>
    <description>five rapid contractions (Flicks) with a 10 second rest before each one (phasic).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recovery time at termination of rapid contraction(second)</measure>
    <time_frame>1 day</time_frame>
    <description>recovery time until all muscles relax</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>average amplitude of tonic contraction(µV)</measure>
    <time_frame>1 day</time_frame>
    <description>five 10 second contractions with a 10 second rest before each one (tonic)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>coefficients of variability for the tonic contraction</measure>
    <time_frame>1 day</time_frame>
    <description>standard deviation divided by amplitudes at tonic contraction period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recovery time at termination of tonic contraction(second)</measure>
    <time_frame>1 day</time_frame>
    <description>recovery time until all muscles relax</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>average amplitude of endurance contraction(µV)</measure>
    <time_frame>1 day</time_frame>
    <description>A 10 second rest followed by a single endurance contraction of 60 seconds (endurance)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>coefficients of variability for the endurance contraction</measure>
    <time_frame>1 day</time_frame>
    <description>standard deviation divided by amplitudes at endurance contraction period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>resting amplitude (µV) post baseline</measure>
    <time_frame>1 day</time_frame>
    <description>after-test one minute rest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>coefficients of variability post baseline</measure>
    <time_frame>1 day</time_frame>
    <description>standard deviation divided by amplitudes at after-test resting period</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Pelvic Floor</condition>
  <eligibility>
    <study_pop>
      <textblock>
        healthy females with no symptoms of pelvic floor dysfunciton and normal contraciton
        strength, and at least 2 yrs postpartum.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  a. Having sex life and tolerable to vaginal examination b. There were no symptoms
             related to pelvic floor dysfunction; c. The modified Oxford grading system was 4 or 5;
             d. No birth or 2 years after the last delivery;

        Exclusion Criteria:

          -  a. Duration of pregnancy and lactation; b. Within 2 years after delivery; c. Acute
             inflammation of vagina or discomfort of vagina; d. History of pelvic floor
             dysfunction: leakage of urine in the past 1 month when coughing / sneezing / lifting;
             leakage of urine in the past 1 month when urgency fecal incontinence in the past 1
             month; usually have a bulge or something falling out that can be seen or felt in
             vaginal area; Pain in the abdomen or lumbosacral and buttocks below the navel for more
             than 6 months; e. History of radical pelvic surgery (cervical cancer, rectal cancer,
             bladder cancer, etc.); f. History of hysterectomy and subtotal hysterectomy; g.
             History of pelvic floor surgery (anti-incontinence and prolapse surgery); h. History
             of pelvic radiotherapy; i. Nervous system diseases that significantly affect muscle
             function; j. Those who can't cooperate with pelvic floor contraction
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>female</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lan Zhu</last_name>
    <role>Principal Investigator</role>
    <affiliation>zhu_julie@vip.sina.com</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juan Chen</last_name>
    <phone>13521354364</phone>
    <email>pumchcj@sina.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Maternal and Child Health Hospital of Anhui Province</name>
      <address>
        <city>Hefei</city>
        <state>Anhui</state>
        <zip>230001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongmei Zhou</last_name>
      <email>1973517466@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital, Chinese Academy of Medical Science</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Chen</last_name>
      <phone>13521354364</phone>
      <email>pumchcj@sina.com</email>
    </contact>
    <investigator>
      <last_name>Lan Zhu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gansu Province Maternal and Child Care Hospital</name>
      <address>
        <city>Lanzhou</city>
        <state>Gansu</state>
        <zip>730050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min Zhou</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Foshan Maternal and Child Health Care Hospital</name>
      <address>
        <city>Foshan</city>
        <state>Guangdong</state>
        <zip>528000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhengxian Xu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>the First Affiliated Hospital of Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huan Ge</last_name>
      <email>huange@njmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Jie Wu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xi'an' Fourth Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinwen Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ningbo Women &amp; Children's Hospital</name>
      <address>
        <city>Ningbo</city>
        <state>Zhejiang</state>
        <zip>315012</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bengui Jiang</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 26, 2020</study_first_submitted>
  <study_first_submitted_qc>January 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2020</study_first_posted>
  <last_update_submitted>January 26, 2020</last_update_submitted>
  <last_update_submitted_qc>January 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

